MyBody-X angle on Abnehmspritze Genetik

MyBody-X's angle on weight loss injections (GLP-1 agonists like semaglutide) is that while genetic variants such as FTO rs9939609 are linked to obesity risk, they are not destiny. The effectiveness of these injections depends heavily on lifestyle, adherence, and medical supervision. Genetic testing can offer insights into metabolic tendencies but cannot replace professional healthcare guidance. Evidence for predicting individual response to GLP-1 drugs based on genetics is still emerging (mostly GWAS and observational studies). MyBody-X recommends using such tests as complementary tools, not as standalone decision-makers. Safety note: weight loss injections are prescription-only and carry potential side effects; genetic predisposition alone does not justify self-medication.